NCT03914144

Brief Summary

Catheterisation is an accepted tool in intrapartum bladder care and indwelling catheters are used routinely before elective caesarean sections. However, urinary catheters are associated with an increased rate of urinary tract infections which can lead to complications including increased maternal morbidity and prolonged hospital stay. A Cochrane Review (2014) concluded that there is insufficient evidence to assess the routine use of indwelling bladder catheters in women undergoing caesarean section. The incidence and causation of catheter-associated infection in this population is unknown. We propose to provide this data, by comparing urine samples from pregnant women before and after their delivery and analysing this against observational catheter use during the delivery. This will be vital in conducting future research into potential change in policy on routine catheterisation. It will also be beneficial to patients as it could reduce the burden of catheterisation by reducing their chance of developing a UTI and by reducing the associated morbidity.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2019

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 11, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
15 days until next milestone

Study Start

First participant enrolled

May 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

April 11, 2019

Last Update Submit

March 23, 2026

Conditions

Keywords

catetherpregnancypostnatal infection

Outcome Measures

Primary Outcomes (1)

  • Postpartum Urinary Tract Infection

    Number of patients diagnosed with a postpartum urinary tract infection within 30 days of delivery. (This is defined as positive MSU (\>107 cfu/l) with associated symptoms.)

    30 days post delivery

Secondary Outcomes (1)

  • Postpartum asymptomatic bacteriuria

    30 days post delivery

Study Arms (4)

Normal Vaginal Delivery

The group of patients who achieved a normal delivery will be retrospectively assessed as to whether they had any episode of catheter insertion during their delivery.

Other: Catheter insertion

Insturmental Vaginal Delivery

The group of patients who underwent instrumental delivery (ventouse or forceps) will be retrospectively assessed as to whether they had any episode of catheter insertion during their delivery.

Other: Catheter insertion

Emergency Caesarean Section

Each patient will be recorded how many catheter episodes occurred during their labour and delivery.

Other: Catheter insertion

Elective Caesarean Section

We expect all patients in this group to have an indwelling catheter sited before their elective caesarean sections, however we will assess each patient individually to confirm whether they had a catheter for their delivery.

Other: Catheter insertion

Interventions

A data collection sheet will be assigned for every patient who is recruited for the study. The clinician caring for the patient will be asked to fill in this form after the delivery has occurred. The form essentially will describe if the patient received any catheter during the delivery and if so, an indwelling catheter or an intermittent (in/out) catheter and how many episodes this occurred.

Elective Caesarean SectionEmergency Caesarean SectionInsturmental Vaginal DeliveryNormal Vaginal Delivery

Eligibility Criteria

Sexfemale
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The target of recruitment is pregnant women from 37 weeks gestation. They will be recruited from the Maternity Triage Department, Antenatal Clinic, Central Delivery Suite, Birth Unit or the Maternity Ward.

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study
  • Intact membranes
  • At least 37 weeks pregnant

You may not qualify if:

  • History of microbiologically-confirmed bacteriuria in preceding 28 days
  • Patients who are in active labour
  • Women who have had either urine-specific or broad-spectrum antibiotics within the last 28 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

Patients are asked to provide 3 samples of urine which are to be processed in the laboratory with routine testing for microscopy, culture and sensitivity and disposed of in the standard way.

MeSH Terms

Interventions

Catheterization

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Study Officials

  • Mark James, MbChb

    Gloucestershire NHS Foundation Trust

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2019

First Posted

April 16, 2019

Study Start

May 1, 2019

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Patient information will be kept confidentially and not shared as per the Data Protection Act 2018